Yang et al. showed that overexpression of CLDN6 in human triple-negative breast cancer cells inhibited cell proliferation and resulted in downregulation of the mesenchymal marker vimentin [72]. The gene discussed is VIM; the disease is triple-negative breast carcinoma.